Home > Search Clinical Trials > All > Trial Details

Clinical Trial Details
Circulating Markers for Ischemic Heart Failure
Clinical Trial ( IRB ) #: 07-252-2
Title: Circulating Markers for Ischemic Heart Failure
Principal Investigator:
Description: The purpose of this research is to determine if two proteins in the blood are increased during acute myocardial infarction and whether their levels are higher in those who develop heart failure than those who do not. These two proteins are produced and potentially released when the heart muscle is damaged. They may then be released into the blood and be detected by standard method in the research laboratory. At this time, detection of an increase in these proteins in the blood is not know to be associated with any disease or myocardial infarction.
Classification:
  Cardiovascular (Heart, High Blood Pressure, Etc.)
Eligibility Criteria: men and women, 18 years of age and over with acute myocardial infarction (determined by positive cardiac markers -CKMB/ troponin) with or without heart failure (dyspnea, rales, edema, elevated jugular venous pressure, ascites). A control group of subjects without history of MI or heart disease.
How to Contact: Fahad Shah. Telephone: (860) 679-7549. Email: fshah@uchc.edu
Enrollment Status/Comments: Enrolling/recruiting. For current recruitment status, please check with study contact.
Web Address: clinicaltrials.gov/ct2/show/NCT00762333?term=%22Connecticut+Health+Center%22&rank=12